Synergistic inhibition of mesothelioma cell growth by the combination of clofarabine and resveratrol involves Nrf2 downregulation
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Yoon-Jin | - |
dc.contributor.author | Im, Jae-Hyuk | - |
dc.contributor.author | Lee, David M. | - |
dc.contributor.author | Park, Ji-Sung | - |
dc.contributor.author | Won, Seong Youn | - |
dc.contributor.author | Cho, Moon-Kyun | - |
dc.contributor.author | Nam, Hae-Seon | - |
dc.contributor.author | Lee, Yong-Jin | - |
dc.contributor.author | Lee, Sang-Han | - |
dc.date.accessioned | 2021-08-12T02:26:40Z | - |
dc.date.available | 2021-08-12T02:26:40Z | - |
dc.date.issued | 2012-11-30 | - |
dc.identifier.issn | 1976-6696 | - |
dc.identifier.issn | 1976-670X | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/14687 | - |
dc.description.abstract | We previously reported that MSTO-211H cells have a higher capacity to regulate Nrf2 activation in response to changes in the cellular redox environment. To further characterize its biological significance, the response of Nrf2, a transcription factor that regulates ARE-containing genes, on the synergistic cytotoxic effect of clofarabine and resveratrol was investigated in mesothelioma cells. The combination treatment showed a marked growth-inhibitory effect, which was accompanied by suppression of Nrf2 activation and decreased expression of heme oxygenase-1 (HO-1). While transient overexpression of Nrf2 conferred protection against the cytotoxicity caused by their combination, knockdown of Nrf2 expression using siRNA enhanced their cytotoxic effect. Pretreatment with Ly294002, a PI3K inhibitor, augmented the decrease in HO-1 level by their combination, whereas no obvious changes were observed in Nrf2 levels. Altogether, these results suggest that the synergistic cylotoxic effect of clofarabine and resveratrol was mediated, at least in part, through suppression of Nrf2 signaling. [BMB Reports 2012; 45(11): 647-652] | - |
dc.format.extent | 6 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | 생화학분자생물학회 | - |
dc.title | Synergistic inhibition of mesothelioma cell growth by the combination of clofarabine and resveratrol involves Nrf2 downregulation | - |
dc.type | Article | - |
dc.publisher.location | 대한민국 | - |
dc.identifier.doi | 10.5483/BMBRep.2012.45.11.111 | - |
dc.identifier.scopusid | 2-s2.0-84871453477 | - |
dc.identifier.wosid | 000312049000008 | - |
dc.identifier.bibliographicCitation | BMB Reports, v.45, no.11, pp 647 - 652 | - |
dc.citation.title | BMB Reports | - |
dc.citation.volume | 45 | - |
dc.citation.number | 11 | - |
dc.citation.startPage | 647 | - |
dc.citation.endPage | 652 | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART001712974 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
dc.relation.journalWebOfScienceCategory | Biochemistry & Molecular Biology | - |
dc.subject.keywordPlus | HEME OXYGENASE-1 EXPRESSION | - |
dc.subject.keywordPlus | CANCER CELLS | - |
dc.subject.keywordPlus | MULTIDRUG-RESISTANCE | - |
dc.subject.keywordPlus | OXIDATIVE STRESS | - |
dc.subject.keywordPlus | HUMAN LUNG | - |
dc.subject.keywordPlus | PATHWAY | - |
dc.subject.keywordPlus | CHEMORESISTANCE | - |
dc.subject.keywordPlus | PROTEINS | - |
dc.subject.keywordPlus | AGENTS | - |
dc.subject.keywordPlus | DRUGS | - |
dc.subject.keywordAuthor | Chemoresistance | - |
dc.subject.keywordAuthor | Clofarabine | - |
dc.subject.keywordAuthor | Mesothelioma | - |
dc.subject.keywordAuthor | Nrf2 | - |
dc.subject.keywordAuthor | Resveratrol | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.